Login / Signup

Correction: The selective estrogen receptor downregulator GDC-0810 is efficacious in diverse models of ER+ breast cancer.

James D JosephBeatrice DarimontWei ZhouAlfonso ArrazateAmy YoungEllen IngallaKimberly WalterRobert A BlakeJim NonomiyaZhengyu GuanLorna KategayaSteven P GovekAndiliy G LaiMehmet KahramanDan BrighamJohn SensintaffarNhin LuGang ShaoJing QianKate GrillotMichael MoonRene PrudenteEric BischoffKyoung-Jin LeeCeline BonnefousKarensa L DouglasJackaline D JulienJohnny Y NagasawaAnna AparicioJosh KaufmanBenjamin HaleyJennifer M GiltnaneIngrid E WertzMark R LacknerMichelle A NanniniDeepak SampathLuis SchwarzHenry Charles ManningMohammed Noor TantawyCarlos L ArteagaRichard A HeymanPeter J RixLori FriedmanNicholas D SmithCiara MetcalfeJeffrey H Hager
Published in: eLife (2019)
Keyphrases
  • estrogen receptor
  • young adults
  • breast cancer risk
  • childhood cancer
  • endoplasmic reticulum